Edoxaban vs low molecular weight heparin in cancer-related VTE; New treatment for cystic fibrosis
Update: 2018-02-20
Description
Today’s UpToDate Talk episode features discussions related to three papers published in the New England Journal of Medicine. Dr. Jess Mandel discusses anticoagulation options for cancer-associated venous thromboembolism, and Dr. George Mallory discusses two studies of tezacaftor-ivacaftor in patients with cystic fibrosis. Segment two begins at 11:32 . Dr. Helen Hollingsworth hosts.
Comments
In Channel